Zobrazeno 1 - 10
of 70
pro vyhledávání: '"Ikuro Matsuba"'
Autor:
Yoko Matsuzawa, Kosuke Azuma, Tasuku Sawa, Yoshiaki Ono, Yoshiro Hamada, Ikuro Matsuba, Akira Kanamori
Publikováno v:
Journal of Diabetes Investigation, Vol 13, Iss 12, Pp 2073-2080 (2022)
Abstract Aims/Introduction To investigate the recognition status of stigma/advocacy in patients with type 2 diabetes in clinical practice settings. Method A questionnaire survey on stigma/advocacy of patients with diabetes was carried out for members
Externí odkaz:
https://doaj.org/article/f44117834bb84c798e58217cb7beea20
Autor:
Ikuro Matsuba, Takehiro Kawata, Kotaro Iemitsu, Taro Asakura, Hikaru Amemiya, Masashi Ishikawa, Syogo Ito, Mizuki Kaneshiro, Akira Kanamori, Akira Kubota, Kazuaki Shinoda, Masahiko Takai, Tetsuo Takuma, Masahiro Takihata, Hiroshi Takeda, Keiji Tanaka, Yoko Matsuzawa, Hideo Machimura, Fuyuki Minagawa, Nobuaki Minami, Atsuko Mokubo, Masaaki Miyakawa, Yasuo Terauchi, Yasushi Tanaka
Publikováno v:
Journal of Diabetes Investigation, Vol 11, Iss 5, Pp 1248-1257 (2020)
Abstract Aims/Introduction Type 2 diabetes mellitus is the leading cause of kidney failure worldwide, but few effective long‐term treatments are available. Methods This was an investigator‐initiated multicenter prospective intervention study in w
Externí odkaz:
https://doaj.org/article/ef16d02909194cbd8964f418883bb465
Autor:
Atsushi Goto, Hirofumi Go, Kei Miyakawa, Yutaro Yamaoka, Norihisa Ohtake, Sousuke Kubo, Sundararaj Stanleyraj Jeremiah, Takahiro Mihara, Kotaro Senuki, Tomoyuki Miyazaki, Satoshi Ikeda, Takashi Ogura, Hideaki Kato, Ikuro Matsuba, Naoko Sanno, Masaaki Miyakawa, Haruo Ozaki, Masakazu Kikuoka, Yasuo Ohashi, Akihide Ryo, Takeharu Yamanaka
Publikováno v:
Frontiers in Microbiology, Vol 12 (2021)
Objective: There is scarce evidence regarding the long-term persistence of neutralizing antibodies among coronavirus disease 2019 (COVID-19) survivors. This study determined neutralizing antibody titers (NT50) and antibodies against spike protein (SP
Externí odkaz:
https://doaj.org/article/ce74df3f08c1470ba28b127ff7579ae5
Autor:
Ikuro, Matsuba, Tetsuo, Takuma, Nobuo, Hatori, Masahiko, Takai, Yoshiyuki, Watanabe, Nobukazu, Takada, Satoru, Kishi, Yoko, Matsuzawa, Tetsuo, Nishikawa, Tomoyuki, Kunishima, Hisakazu, Degawa, Masanori, Nishikawa, Yoshiaki, Ono, Masaaki, Miyakawa, Yutaka, Hatori, Akira, Kanamori
Publikováno v:
Internal Medicine. 61:3053-3062
Objective To examine the continuation of antibody prevalence status after 12 months and background factors in antibody-positive subjects following asymptomatic infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Methods We in
Autor:
Ikuro, Matsuba, Takehiro, Kawata, Miho, Ajima, Shinichi, Umezawa, Mizuki, Kaneshiro, Taro, Asakura, Hideo, Machimura, Tasuku, Sawa, Keiji, Tanaka, Hiroshi, Takeda, Takeshi, Imaoka, Akira, Kanamori
Publikováno v:
Diabetes Therapy. 13:265-274
MOSAIc was a multinational, non-interventional, prospective, observational cohort study designed to provide an understanding of the specific challenges associated with intensification of initial insulin therapy in patients with type 2 diabetes mellit
Autor:
Yoshiyuki Watanabe, Ikuro Matsuba, Karin Watanabe, Tomoyuki Kunishima, Yukako Takechi, Tetsuo Takuma, Yasushi Araki, Nobuo Hirotsu, Hiroyuki Sakai, Ritsuko Oikawa, Hiroki Danno, Masakazu Fukuda, Seiji Futagami, Kota Wada, Hiroyuki Yamamoto, Fumio Itoh, Ichiro Oda, Yutaka Hatori, Hisakazu Degawa
Publikováno v:
Journal of Clinical Laboratory Analysis. 36
Coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a global pandemic even after vaccination. We aimed to identify immunological heterogeneity over time in vaccinated healthcare workers usi
Autor:
Yoshiyuki Watanabe, Ikuro Matsuba, Masanori Nishikawa, Hisakazu Degawa, Yoko Matsuzawa, Tetsuo Nishikawa, Norihiko Koido, Futoshi Ebara, Yoshiaki Ono, Akira Kanamori, Nobuo Hatori, Tomoyuki Kunishima
Publikováno v:
Journal of Infection and Chemotherapy
Objectives We investigated relationships between subclinical COVID-19 (coronavirus disease 2019) and background factors. Methods We determined SARS-CoV-2 antibody (IgG) prevalence in 1603 patients, doctors, and nurses in 65 medical institutions in Ka
Autor:
Akira Kanamori, Masahiro Takihata, Kotaro Iemitsu, Hikaru Amemiya, Mizuki Kaneshiro, Yoko Matsuzawa, Masashi Ishikawa, Keiji Tanaka, Hiroshi Takeda, Kazuaki Shinoda, Akira Kubota, Takehiro Kawata, Tetsuo Takuma, Nobuaki Minami, Yasushi Tanaka, Hideo Machimura, Ikuro Matsuba, Atsuko Mokubo, Masaaki Miyakawa, Masahiko Takai, Yasuo Terauchi, Syogo Ito, Taro Asakura, Fuyuki Minagawa
Publikováno v:
Journal of Diabetes Investigation, Vol 11, Iss 5, Pp 1248-1257 (2020)
Journal of Diabetes Investigation
Journal of Diabetes Investigation
Aims/Introduction Type 2 diabetes mellitus is the leading cause of kidney failure worldwide, but few effective long‐term treatments are available. Methods This was an investigator‐initiated multicenter prospective intervention study in which ipra
Autor:
Atsuko Mokubo, Masahiko Takai, Mizuki Kaneshiro, Takehiro Kawata, Akira Kanamori, Yasushi Tanaka, Tetsuo Takuma, Ikuro Matsuba, Akira Kubota, Mitsuo Obana, Shinichi Umezawa, Taisuke Kikuchi, Hideo Machimura, Hiroshi Takeda, Yoko Matsuzawa, Tetsuya Motomiya, Masahiro Takihata, Kotaro Iemitsu, Hajime Maeda, Masaaki Miyakawa, Shogo Ito, Yasuo Terauchi, Taro Asakura
Publikováno v:
Diabetes Technology & Therapeutics. 22:228-234
Background: Sodium/glucose cotransporter-2 (SGLT2) inhibitors improve glycemic control and reduce body weight by increasing glycosuria. Although a compensatory increase of food intake has been repo...
Autor:
Akira Kanamori, Tetsuya Motomiya, Masahiko Takai, Hiroshi Takeda, Kotaro Iemitsu, Atsuko Mokubo, Hajime Maeda, Fuyuki Minagawa, Akira Kubota, Masashi Ishikawa, Takehiro Kawata, Tetsuo Takuma, Shinichi Umezawa, Keiji Tanaka, Hideo Machimura, Ikuro Matsuba
Publikováno v:
Journal of Clinical Medicine Research
Background: There are several reports of seasonal variation in hemoglobin A1c (HbA1c) in patients with type 2 diabetes (T2DM), but no reports of seasonal variation in the effect of add-on drugs on blood glucose control in insulin-treated patients. Me